Pacira BioSciences, Inc. (PCRX): Depreciation & Amortization
$91.02M
Year ended 2025-12-31
$85.16M
Trailing 12 months to 2026-06-30
-0.2%
3-year compound annual growth
+35.5%
5-year compound annual growth
+23.0%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $91.02M | +15.5% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $78.78M | +4.2% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $75.57M | -17.4% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $91.50M | +220.5% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $28.55M | +43.4% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $19.91M | +1.7% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $19.58M | +48.7% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $13.16M | -4.8% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $13.83M | +7.1% | 2020-02-21, From 2017-01-01 |
| 2016-12-31 | $12.92M | +12.6% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $11.47M | +14.3% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $10.04M | +74.6% | 2016-02-25, From 2014-01-01 |
| 2013-12-31 | $5.75M | +1.8% | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | $5.65M | +30.9% | 2015-02-24, From 2012-01-01 |
| 2011-12-31 | $4.31M | +6.0% | 2014-02-25, From 2011-01-01 |
| 2010-12-31 | $4.07M | -1.8% | 2013-03-07, From 2010-01-01 |
| 2009-12-31 | $4.15M | n/a | 2012-03-27, From 2009-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $91.02M | +15.5% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $91.56M | +13.9% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $95.80M | -11.9% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $1.15M | +44.5% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $1.55M | -8.3% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | $35.00M | -2.8% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $22.20M | +31.4% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $59.0K | -13.2% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $91.63M | -6.7% |
Compare PCRX, SUPN, EBS, CORT side by side · Screen every company in Pharmaceutical Preparations ↗